ground substance

**Composition** - **Glycosaminoglycans (GAGs):** long, unbranched, negatively charged repeating disaccharides (amino sugar + uronic acid). Examples: hyaluronic acid (hyaluronan; the only non-sulfated GAG, not covalently bound to a protein core), chondroitin sulfate, dermatan sulfate, keratan sulfate, heparan sulfate, heparin. The negative charge attracts Na+ and water, giving turgor and resistance to compression. - **Proteoglycans:** GAGs covalently attached to a core protein (e.g., aggrecan in cartilage, which binds hyaluronan via link proteins; syndecan; perlecan in basement membranes). Often described as "bottle-brush" structures. - **Multiadhesive glycoproteins:** fibronectin (binds integrins, collagen, and GAGs), laminin (basement membrane), chondronectin, and tenascin. They anchor cells to the ECM. - Water makes up much of its volume, so it behaves as a hydrated gel.

**Functions** - Resists compressive forces (e.g., articular cartilage, nucleus pulposus of intervertebral disc, vitreous humor). - Medium for diffusion of nutrients, O2, and waste between capillaries and cells. - Lubrication (synovial fluid is rich in hyaluronan). - Cell adhesion, migration, and signaling (growth factor binding, e.g., heparan sulfate binds FGF). - Barrier to bacterial spread. Hyaluronidase, produced by Streptococcus pyogenes, Staphylococcus aureus, and Clostridium perfringens, degrades hyaluronic acid and acts as a "spreading factor." - Heparin (in mast cell granules) and heparan sulfate (on endothelium) activate antithrombin III (anticoagulant).

**Clinical correlations** - **Mucopolysaccharidoses (lysosomal storage diseases):** deficiency of lysosomal enzymes that degrade GAGs. - Hurler syndrome: α-L-iduronidase deficiency. Corneal clouding, coarse facies, hepatosplenomegaly, developmental delay. Accumulation of heparan and dermatan sulfate. - Hunter syndrome: iduronate-2-sulfatase deficiency, X-linked recessive. Mild course, no corneal clouding, aggressive behavior ("Hunters see clearly"). - **Osteoarthritis:** loss of proteoglycans (aggrecan) and degradation of the cartilage matrix. - **Marfan syndrome:** fibrillin-1 defect affecting the ECM; the related ECM changes include cystic medial degeneration with excess mucoid ground substance in the aortic media. - **Hypothyroidism (myxedema):** accumulation of GAGs (hyaluronic acid, chondroitin sulfate) in the dermis causes nonpitting edema. Similar GAG deposition occurs in pretibial myxedema in Graves disease. - **Aging skin and photodamage:** decreased hyaluronic acid and altered GAGs. Hyaluronic acid fillers are used cosmetically. - **Scurvy, Ehlers-Danlos, and osteogenesis imperfecta** affect the fibrous component (collagen) of the ECM rather than the ground substance, a common distinction on exams.

**High-yield distinctions** - Ground substance = amorphous gel (GAGs, proteoglycans, glycoproteins). ECM = ground substance + fibers (collagen, elastic, reticular). - Basement membrane has its own specialized matrix: type IV collagen, laminin, heparan sulfate (perlecan), and entactin. Loss of heparan sulfate's negative charge in the glomerular basement membrane contributes to proteinuria in nephrotic syndrome. - Ground substance is not stained well by routine H&E, so it appears as clear space. It stains with PAS, alcian blue, and colloidal iron.